Skip to content
UniqueBaseEN
For AI ↗
Companies

Opsin

Opsin is a company headquartered in United States.

Snapshot

As of Oct 22, 2026, UniqueBase lists 1 funding record for Opsin; the latest is $21M on Oct 15, 2026.

Funding records
1
Latest round
$21M
Consideration (USD)
—
Total raised (reported)
—
Rows with a source link
1 of 1

Overview

AI drug R&D company, USD 21 million financing completed

Funding

Funding

Amounts as reported; USD estimates shown only when they match
Latest round
$21M
2026-10
Records
1
1 month · all drawn

Data noteListed 1 funding record. Latest funding: $21M, Oct 15, 2026.

Funding events by monthUSD estimate
Funding events by monthEach dot is one funding record on its month. An empty month has no recorded round: it is not filled with zero, and the dots are not connected. Amounts are reconciled USD estimates and are not summed.2026-10$10M$20M$30M2026-10 funding $21M
Each dot is one funding record on its month. An empty month has no recorded round: it is not filled with zero, and the dots are not connected. Amounts are reconciled USD estimates and are not summed.
DateFunding estimateConsideration (USD)InvestorsSources
Oct 15, 2026$21M—Race Capital, SYN Ventures 1 source Source ↗

Select ▸ on a row to see its source brief and links.

Team, products & investors

Team

No published people profiles are linked yet.

Products

No published product profiles are linked yet.

Investors & institutions

Race CapitalInvestors ↗SYN VenturesInvestors ↗

Other connected profiles

AI drug R&D company Opsin raises USD 21 millionNews ↗

Explore

United StatesCountry ↗
Sources · 0

Sources & provenance

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

AI药物研发 AI药物研发公司，完成2100万美元融资

JSON ↗Markdown ↗